Table of Contents
International Scholarly Research Notices
Volume 2016, Article ID 1346026, 7 pages
http://dx.doi.org/10.1155/2016/1346026
Review Article

Guidelines for Reporting Medical Research: A Critical Appraisal

1Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark
2Department of Dermatology, Bispebjerg Hospital, 2400 Copenhagen NV, Denmark

Received 12 December 2015; Accepted 9 March 2016

Academic Editor: Giuseppe Biondi-Zoccai

Copyright © 2016 Mathilde Johansen and Simon Francis Thomsen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Atkins, D. Best, P. A. Briss et al., “Grading quality of evidence and strength of recommendations,” British Medical Journal, vol. 328, no. 7454, 1490 pages, 2004. View at Google Scholar
  2. D. G. Altman, D. Moher, and K. F. Schulz, “Improving the reporting of randomised trials: the CONSORT statement and beyond,” Statistics in Medicine, vol. 31, no. 25, pp. 2985–2997, 2012. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  3. K. F. Schulz, D. G. Altman, and D. Moher, “CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials,” Journal of Pharmacology & Pharmacotherapeutics, vol. 1, no. 2, pp. 100–107, 2010. View at Publisher · View at Google Scholar
  4. P. M. Bossuyt, J. B. Reitsma, D. E. Bruns et al., “Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative,” British Medical Journal, vol. 326, no. 7379, pp. 41–44, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. The EQUATOR Network, http://www.equator-network.org.
  6. D. Mainland, The Treatment of Clinical and Laboratory data, Oliver & Boyd, Edinburgh, Scotland, 1938.
  7. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” Annals of Internal Medicine, vol. 151, no. 4, pp. 264–269, 2009. View at Google Scholar · View at Scopus
  8. C. D. Mulrow, “The medical review article: state of the science,” Annals of Internal Medicine, vol. 106, no. 3, pp. 485–488, 1987. View at Publisher · View at Google Scholar · View at Scopus
  9. H. S. Sacks, J. Berrier, D. Reitman, V. A. Ancona-Berk, and T. C. Chalmers, “Meta-analyses of randomized controlled trials,” The New England Journal of Medicine, vol. 316, no. 8, pp. 450–455, 1987. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Moher, D. J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D. F. Stroup, “Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement,” The Lancet, vol. 354, no. 9193, pp. 1896–1900, 1999. View at Publisher · View at Google Scholar
  11. N. Panic, E. Leoncini, G. de Belvis, W. Ricciardi, and S. Boccia, “Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses,” PLoS ONE, vol. 8, no. 12, Article ID e83138, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. K. F. Schulz, L. Chalmers, R. J. Hayes, and D. G. Altman, “Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials,” The Journal of the American Medical Association, vol. 273, no. 5, pp. 408–412, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. D. G. Altman, “Transparent reporting of trials is essential,” The American Journal of Gastroenterology, vol. 108, no. 8, pp. 1231–1235, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Moher, A. Jones, L. Lepage, and CONSORT Group (Consolidated Standards for Reporting of Trials), “Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation,” Journal of the American Medical Association, vol. 285, no. 15, pp. 1992–1995, 2001. View at Publisher · View at Google Scholar
  15. E. von Elm, D. G. Altman, M. Egger, S. J. Pocock, P. C. Gøtzsche, and J. P. Vandenbroucke, “The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies,” International Journal of Surgery, vol. 12, no. 12, pp. 1495–1499, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Lee, J. Bindman, T. Ford et al., “Bias in psychiatric case-control studies. Literature survey,” British Journal of Psychiatry, vol. 190, pp. 204–209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. J. Pocock, T. J. Collier, K. J. Dandreo et al., “Issues in the reporting of epidemiological studies: a survey of recent practice,” British Medical Journal, vol. 329, no. 7471, pp. 883–887, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Little, J. P. Higgins, J. P. Ioannidis et al., “Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement,” Annals of Internal Medicine, vol. 150, no. 3, pp. 206–215, 2009. View at Publisher · View at Google Scholar
  19. D. F. Stroup, J. A. Berlin, S. C. Morton et al., “Meta-analysis of observational studies in epidemiology: a proposal for reporting,” The Journal of the American Medical Association, vol. 283, no. 15, pp. 2008–2012, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. J. G. Lijmer, B. W. Mol, S. Heisterkamp et al., “Empirical evidence of design-related bias in studies of diagnostic tests,” The Journal of the American Medical Association, vol. 282, no. 11, pp. 1061–1066, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. P. M. M. Bossuyt, “STARD statement: still room for improvement in the reporting of diagnostic accuracy studies,” Radiology, vol. 248, no. 3, pp. 713–714, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. D. A. Korevaar, W. A. van Enst, R. Spijker, P. M. M. Bossuyt, and L. Hooft, “Reporting quality of diagnostic accuracy studies: a systematic review and meta-analysis of investigations on adherence to STARD,” Evidence-Based Medicine, vol. 19, no. 2, pp. 47–54, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. P. Vandenbroucke, “STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK... and CONSORT: for whom does the guideline toll?” Journal of Clinical Epidemiology, vol. 62, no. 6, pp. 594–596, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D. A. Korevaar, J. Wang, W. A. van Enst et al., “Reporting diagnostic accuracy studies: some improvements after 10 years of STARD,” Radiology, vol. 274, no. 3, pp. 781–789, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. A.-W. Chan, J. M. Tetzlaff, D. G. Altman et al., “SPIRIT 2013 statement: defining standard protocol items for clinical trials,” Annals of Internal Medicine, vol. 158, no. 3, pp. 200–207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Tetzlaff, A.-W. Chan, J. Kitchen, M. Sampson, A. C. Tricco, and D. Moher, “Guidelines for randomized clinical trial protocol content: a systematic review,” Systematic Reviews, vol. 1, no. 1, article 43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. COPE, http://publicationethics.org/.
  28. A. E. Fung, R. Palanki, S. J. Bakri, E. Depperschmidt, and A. Gibson, “Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies,” Ophthalmology, vol. 116, no. 2, pp. 286–296, 2009. View at Publisher · View at Google Scholar · View at Scopus